Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yagmur Akdag

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmaceutical Development and Technology|January 5, 2023
Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibilityYagmur Akdag
International Journal of Pharmaceutics|June 22, 2019
Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0Reza Vatankhah Barenji, Yagmur Akdag, Barbaros Yet, et al.
Current Pharmaceutical Design|September 24, 2024
Optimization of Glyburide-loaded Nanosuspensions <i>via</i> Ball Milling and Homogenization Techniques: A Central Composite Design Approach for Enhanced SolubilityDamla Gungor, Eren Aytekin, Yagmur Akdag, et al.
Pharmaceutical Development and Technology|May 21, 2020
Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tabletsTugba Gulsun, Yagmur Akdag, Nihan Izat, et al.
Current Neuropharmacology|April 16, 2025
Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's DiseaseBüşra Öztürk, Huriye Demir, Mine Silindir Günay, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 6, 2025
Application of artificial neural network to determine optimum formulation development and in vitro characterization of methylene blue and galantamine loaded polymeric nanoparticles for the treatment of Alzheimer's diseaseBusra Ozturk, Huriye Demir, Mine Silindir-Gunay, et al.
Drug Development and Industrial Pharmacy|April 20, 2017
Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patientsYagmur Akdag Cayli, Selma Sahin, Francesca Buttini, et al.
Journal of Pharmaceutical Sciences|November 16, 2025
Assessment of intranasal permeability and pharmacological activity of glyburide-loaded nanosuspension formulation for Alzheimer's diseaseDamla Gungor, Semsi Muratoglu, Eren Aytekin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutical Development and Technology|January 5, 2023
Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibilityYagmur Akdag
International Journal of Pharmaceutics|June 22, 2019
Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0Reza Vatankhah Barenji, Yagmur Akdag, Barbaros Yet, et al.
Current Pharmaceutical Design|September 24, 2024
Optimization of Glyburide-loaded Nanosuspensions <i>via</i> Ball Milling and Homogenization Techniques: A Central Composite Design Approach for Enhanced SolubilityDamla Gungor, Eren Aytekin, Yagmur Akdag, et al.
Pharmaceutical Development and Technology|May 21, 2020
Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tabletsTugba Gulsun, Yagmur Akdag, Nihan Izat, et al.
Current Neuropharmacology|April 16, 2025
Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's DiseaseBüşra Öztürk, Huriye Demir, Mine Silindir Günay, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 6, 2025
Application of artificial neural network to determine optimum formulation development and in vitro characterization of methylene blue and galantamine loaded polymeric nanoparticles for the treatment of Alzheimer's diseaseBusra Ozturk, Huriye Demir, Mine Silindir-Gunay, et al.
Drug Development and Industrial Pharmacy|April 20, 2017
Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patientsYagmur Akdag Cayli, Selma Sahin, Francesca Buttini, et al.
Journal of Pharmaceutical Sciences|November 16, 2025
Assessment of intranasal permeability and pharmacological activity of glyburide-loaded nanosuspension formulation for Alzheimer's diseaseDamla Gungor, Semsi Muratoglu, Eren Aytekin, et al.
Pageof 1